23andMe ft. Anne Wojcicki - How a DNA startup took on the FDA and redefined health tech
Description
Millions of customers have explored their genome with 23andMe. But when the company started in 2006, the idea of consumer DNA testing was heresy to the medical establishment. The FDA once even ordered 23andMe to stop selling its health testing product. The company persevered to make allies out of adversaries, and became the only FDA-approved product on the market. Learn how 23andMe defined the DNA testing category, and used its success to enter the massive new field of drug discovery.
Host: Roelof Botha, Sequoia Capital
Featuring: Anne Wojcicki, Richard Scheller
Transcript: https://www.sequoiacap.com/podcast/crucible-moments-23andMe/
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Founder Matthew Rabinowitz opens up about the intensely personal journey that set him on a course to revolutionizing healthcare. A PhD in electrical engineering, he had no background in genetics or biology, but after his sister had a baby with Down syndrome that hadn’t been detected and...
Published 11/21/24
Tony Xu and Miki Kuusi share insights from building two of the world's most successful delivery platforms—DoorDash and Wolt—which merged in 2022 to create an $80B GOV business operating in 32 countries. In this candid conversation with Sequoia's Alfred Lin live at a Sequoia event in Europe, they...
Published 11/14/24